ByHeart Says FDA Has “No Further Questions.” Release the Submission and the Letter.

ByHeart announced the FDA has no further questions regarding its root cause investigation and action plan following a 2025 infant botulism outbreak, though the FDA has not yet determined the root cause nor approved production resumption. The company is changing ingredient suppliers and treatment methods before restarting production.

This Wire brief sits within Fusion42's coverage of Foodtech.